M. KANKO Et Al. , "Ischemia-modified albumin use as a prognostic factor in patients that undergo coronary bypass surgery," The Seventh Annual Congress of Uptade in Cardiology and Cardiovascular Surgery in association with TCT Mediterranean Congress , 2011
KANKO, M. Et Al. 2011. Ischemia-modified albumin use as a prognostic factor in patients that undergo coronary bypass surgery. The Seventh Annual Congress of Uptade in Cardiology and Cardiovascular Surgery in association with TCT Mediterranean Congress .
KANKO, M., YAVUZ, Ş., HOŞTEN, T., DUMAN, C., & ÖNER, E., (2011). Ischemia-modified albumin use as a prognostic factor in patients that undergo coronary bypass surgery . The Seventh Annual Congress of Uptade in Cardiology and Cardiovascular Surgery in association with TCT Mediterranean Congress
KANKO, MUHİP Et Al. "Ischemia-modified albumin use as a prognostic factor in patients that undergo coronary bypass surgery," The Seventh Annual Congress of Uptade in Cardiology and Cardiovascular Surgery in association with TCT Mediterranean Congress, 2011
KANKO, MUHİP Et Al. "Ischemia-modified albumin use as a prognostic factor in patients that undergo coronary bypass surgery." The Seventh Annual Congress of Uptade in Cardiology and Cardiovascular Surgery in association with TCT Mediterranean Congress , 2011
KANKO, M. Et Al. (2011) . "Ischemia-modified albumin use as a prognostic factor in patients that undergo coronary bypass surgery." The Seventh Annual Congress of Uptade in Cardiology and Cardiovascular Surgery in association with TCT Mediterranean Congress .
@conferencepaper{conferencepaper, author={MUHİP KANKO Et Al. }, title={Ischemia-modified albumin use as a prognostic factor in patients that undergo coronary bypass surgery}, congress name={The Seventh Annual Congress of Uptade in Cardiology and Cardiovascular Surgery in association with TCT Mediterranean Congress}, city={}, country={}, year={2011}}